Variations in lipid levels according to menstrual cycle phase: Clinical implications

Sunni L. Mumford, Sonya Dasharathy, Anna Z. Pollack, Enrique F. Schisterman

Research output: Contribution to journalArticle

Abstract

Understanding variations in lipoprotein cholesterol levels throughout the menstrual cycle is important because there may be clinical implications regarding the appropriate timing of measurement and implications on the design and interpretation of studies in women of reproductive age. Our objective was to review the evidence comparing lipoprotein cholesterol levels throughout the menstrual cycle among premenopausal women. Overall, lipoprotein cholesterol levels were observed to vary in response to changing estrogen levels. Taken together, the evidence suggests that total cholesterol and LDL-C tend to be highest during the follicular phase and to decline during the luteal phase, with HDL-C highest around ovulation. Based on these findings, the menstrual cycle phase should be taken into account when evaluating lipoprotein cholesterol levels among reproductive-aged women. Measuring cholesterol levels during menses is recommended for consistent comparisons as this phase can be more reliably identified than other phases, although women within National Cholesterol Education Program acceptable ranges, but near the boundaries when tested during menses, should undergo additional tests.

Original languageEnglish (US)
Pages (from-to)225-234
Number of pages10
JournalClinical Lipidology
Volume6
Issue number2
DOIs
StatePublished - Apr 2011
Externally publishedYes

Fingerprint

Menstrual Cycle
Lipids
Menstruation
Cholesterol
Follicular Phase
Luteal Phase
Ovulation
LDL Cholesterol
Estrogens
Education
lipoprotein cholesterol

Keywords

  • cholesterol
  • estrogen
  • lipoprotein
  • menstrual cycle

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Mumford, S. L., Dasharathy, S., Pollack, A. Z., & Schisterman, E. F. (2011). Variations in lipid levels according to menstrual cycle phase: Clinical implications. Clinical Lipidology, 6(2), 225-234. https://doi.org/10.2217/clp.11.9

Variations in lipid levels according to menstrual cycle phase : Clinical implications. / Mumford, Sunni L.; Dasharathy, Sonya; Pollack, Anna Z.; Schisterman, Enrique F.

In: Clinical Lipidology, Vol. 6, No. 2, 04.2011, p. 225-234.

Research output: Contribution to journalArticle

Mumford, SL, Dasharathy, S, Pollack, AZ & Schisterman, EF 2011, 'Variations in lipid levels according to menstrual cycle phase: Clinical implications', Clinical Lipidology, vol. 6, no. 2, pp. 225-234. https://doi.org/10.2217/clp.11.9
Mumford, Sunni L. ; Dasharathy, Sonya ; Pollack, Anna Z. ; Schisterman, Enrique F. / Variations in lipid levels according to menstrual cycle phase : Clinical implications. In: Clinical Lipidology. 2011 ; Vol. 6, No. 2. pp. 225-234.
@article{510ddd6b87864edbbbe1c1ed0816b9e6,
title = "Variations in lipid levels according to menstrual cycle phase: Clinical implications",
abstract = "Understanding variations in lipoprotein cholesterol levels throughout the menstrual cycle is important because there may be clinical implications regarding the appropriate timing of measurement and implications on the design and interpretation of studies in women of reproductive age. Our objective was to review the evidence comparing lipoprotein cholesterol levels throughout the menstrual cycle among premenopausal women. Overall, lipoprotein cholesterol levels were observed to vary in response to changing estrogen levels. Taken together, the evidence suggests that total cholesterol and LDL-C tend to be highest during the follicular phase and to decline during the luteal phase, with HDL-C highest around ovulation. Based on these findings, the menstrual cycle phase should be taken into account when evaluating lipoprotein cholesterol levels among reproductive-aged women. Measuring cholesterol levels during menses is recommended for consistent comparisons as this phase can be more reliably identified than other phases, although women within National Cholesterol Education Program acceptable ranges, but near the boundaries when tested during menses, should undergo additional tests.",
keywords = "cholesterol, estrogen, lipoprotein, menstrual cycle",
author = "Mumford, {Sunni L.} and Sonya Dasharathy and Pollack, {Anna Z.} and Schisterman, {Enrique F.}",
year = "2011",
month = "4",
doi = "10.2217/clp.11.9",
language = "English (US)",
volume = "6",
pages = "225--234",
journal = "Future Lipidology",
issn = "1746-0875",
publisher = "Future Medicine Ltd.",
number = "2",

}

TY - JOUR

T1 - Variations in lipid levels according to menstrual cycle phase

T2 - Clinical implications

AU - Mumford, Sunni L.

AU - Dasharathy, Sonya

AU - Pollack, Anna Z.

AU - Schisterman, Enrique F.

PY - 2011/4

Y1 - 2011/4

N2 - Understanding variations in lipoprotein cholesterol levels throughout the menstrual cycle is important because there may be clinical implications regarding the appropriate timing of measurement and implications on the design and interpretation of studies in women of reproductive age. Our objective was to review the evidence comparing lipoprotein cholesterol levels throughout the menstrual cycle among premenopausal women. Overall, lipoprotein cholesterol levels were observed to vary in response to changing estrogen levels. Taken together, the evidence suggests that total cholesterol and LDL-C tend to be highest during the follicular phase and to decline during the luteal phase, with HDL-C highest around ovulation. Based on these findings, the menstrual cycle phase should be taken into account when evaluating lipoprotein cholesterol levels among reproductive-aged women. Measuring cholesterol levels during menses is recommended for consistent comparisons as this phase can be more reliably identified than other phases, although women within National Cholesterol Education Program acceptable ranges, but near the boundaries when tested during menses, should undergo additional tests.

AB - Understanding variations in lipoprotein cholesterol levels throughout the menstrual cycle is important because there may be clinical implications regarding the appropriate timing of measurement and implications on the design and interpretation of studies in women of reproductive age. Our objective was to review the evidence comparing lipoprotein cholesterol levels throughout the menstrual cycle among premenopausal women. Overall, lipoprotein cholesterol levels were observed to vary in response to changing estrogen levels. Taken together, the evidence suggests that total cholesterol and LDL-C tend to be highest during the follicular phase and to decline during the luteal phase, with HDL-C highest around ovulation. Based on these findings, the menstrual cycle phase should be taken into account when evaluating lipoprotein cholesterol levels among reproductive-aged women. Measuring cholesterol levels during menses is recommended for consistent comparisons as this phase can be more reliably identified than other phases, although women within National Cholesterol Education Program acceptable ranges, but near the boundaries when tested during menses, should undergo additional tests.

KW - cholesterol

KW - estrogen

KW - lipoprotein

KW - menstrual cycle

UR - http://www.scopus.com/inward/record.url?scp=79953816850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953816850&partnerID=8YFLogxK

U2 - 10.2217/clp.11.9

DO - 10.2217/clp.11.9

M3 - Article

C2 - 21743815

AN - SCOPUS:79953816850

VL - 6

SP - 225

EP - 234

JO - Future Lipidology

JF - Future Lipidology

SN - 1746-0875

IS - 2

ER -